share_log

UBS Maintains Buy on Applied Therapeutics, Raises Price Target to $13

Benzinga ·  Mar 15 08:46

UBS analyst Esther Rajavelu maintains Applied Therapeutics (NASDAQ:APLT) with a Buy and raises the price target from $12 to $13.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment